535 filings
Page 5 of 27
8-K
f2tq6zo4a1
30 Apr 21
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
pa6xl
18 Mar 21
Additional proxy soliciting materials
5:04pm
8-K
y931vl olu
4 Feb 21
Departure of Directors or Certain Officers
5:00pm
8-K
kiy4vcso co3e3v1jp
21 Jan 21
Entry into a Material Definitive Agreement
5:14pm
424B5
1ddld7nggnbsij95e47v
21 Jan 21
Prospectus supplement for primary offering
5:11pm
S-3MEF
q4059rd9l7il67kew
20 Jan 21
Registration of additional securities for an S-3
9:59pm
424B5
hyodw z38u
20 Jan 21
Prospectus supplement for primary offering
5:05pm
8-K
fjbchg 2atyadyg
19 Jan 21
Entry into a Material Definitive Agreement
5:00pm
8-K
amtv8nyjc8r 10h1xiv
13 Nov 20
OncoSec Announces Positive Interim Data from
5:15pm
8-K
h2dr06eoh9
29 Oct 20
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
5:00pm
8-K
xsj9u5pgvu4eq
13 Oct 20
Departure of Directors or Certain Officers
5:15pm
424B5
xrp94sme
17 Aug 20
Prospectus supplement for primary offering
11:04am
8-K
ef5uqhyrsrm rg4f9v
17 Aug 20
Entry into a Material Definitive Agreement
9:36am
8-K
6y9bczxdohn8
27 Jul 20
Departure of Directors or Certain Officers
4:30pm